Health Canada changes listing for melatonin or its salts so prescription is now needed to use melatonin or its salts for pediatric sleep-related issues.
Parent advocates have been urging changes to a policy that sets out responsibilities of school boards, principals and staff when it comes to children with anaphylaxis, asthma, diabetes and epilepsy.
A new study suggests that patients are at increased risk of drug toxicity even before treatment begins, at the start of treatment, and when combined with benzodiazepines and opioids.
Kisunla (donanemab) is a new IV anti-amyloid beta-directed monoclonal antibody for adults with mild cognitive impairment or mild dementia due to Alzheimer's disease.